NT-proBNP and BNP as Biomarkers for Preeclampsia: A Systematic Review and Meta-Analysis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136272 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Viorela-Elena Suciu und 9 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Obstetrics and Gynecology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400610 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Pre-Eclampsia, Natriuretic Peptide, Brain, Biomarkers, Peptide Fragments. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of this study was to evaluate and synthesize the existing evidence on N-terminal pro-brain natriuretic peptide (NT-proBNP) and brain natriuretic peptide (BNP) as biomarkers for preeclampsia as compared with a healthy pregnant group, but also comparing them in early-onset preeclampsia (EOP) versus late-onset preeclampsia (LOP). Five electronic databases, PubMed, EMBASE, Web of Science, Scopus, and LILACS, were searched for studies on pregnant women comparing NT-proBNP and BNP levels in preeclampsia vs. healthy pregnancies and EOP vs. LOP. From the 752 identified records, 31 studies were included in the review, referring to 3915 participants. When comparing PE to healthy pregnancies and EOP to LOP, there was a considerable increase in NT-proBNP levels in the PE group, respectively, in EOP: 206.19 pg/mL (95% CI 139.68–272.69) (p ≤ 0.001) in the PE group, and 182.42 pg/mL (95% CI 99.65–265.19) (p ≤ 0.001) in the EOP group. Regarding BNP, the levels were higher in the PE group (30.13 (95% CI 17.22–43.04), p ≤ 0.001), respectively in the EOP group (33.35 pg/mL (95% CI 20.26–46.43), p ≤ 0.001). NT-proBNP and BNP levels are consistently elevated in preeclampsia compared to healthy pregnancies and in EOP compared to LOP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 2nd Department of Obstetrics and Gynecology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400610 Cluj-Napoca, Romania.
- Department of Medical Informatics and Biostatistics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
- Emergency Military Clinical Hospital "Dr. Constantin Papilian", 400610 Cluj-Napoca, Romania.
ORCID-Profile: Viorela-Elena Suciu, Daniel-Corneliu Leucuța
Zitieren
APA
Suciu, V. E., Leucuța, D. C., Măluțan, A. M., Iuhas, C., Oancea, M., Bucuri, C. E., Roman, M. P., Ormindean, C., Mihu, D., & Ciortea, R. (2025). NT-proBNP and BNP as Biomarkers for Preeclampsia: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136272
Vancouver
Suciu VE, Leucuța DC, Măluțan AM, Iuhas C, Oancea M, Bucuri CE, et al. NT-proBNP and BNP as Biomarkers for Preeclampsia: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136272
BibTeX
@article{Suciu2025,
author = {Suciu, Viorela-Elena and Leucuța, Daniel-Corneliu and Măluțan, Andrei Mihai and Iuhas, Cristian and Oancea, Mihaela and Bucuri, Carmen Elena and Roman, Maria Patricia and Ormindean, Cristina and Mihu, Dan and Ciortea, Răzvan},
title = {NT-proBNP and BNP as Biomarkers for Preeclampsia: A Systematic Review and Meta-Analysis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136272}
}
EUVIMED